News

In the News

In partnership with our network partners, together, we have shared research on real-world treatment patterns in breast and non-small cell lung cancer.

Hero News

Events

Webinar

Syapse Real-World Dialogue: Advancing Patient Care through Real-World Data, Machine Learning, and Systems Biology

September 21, 2022

It’s estimated that less than 5% of adult cancer patients enroll in clinical trials. Due to clinical trial eligibility criteria and access barriers to clinical trials, it is assumed that clinical trial results and the derived clinical evidence have limited generalizability. This creates a gap in needed data and evidence for development of novel therapeutics that will benefit the greatest number of patients, and has most certainly contributed to health care disparities. The next installment of “Real-World Dialogues” will focus on leveraging real-world data, machine learning, and systems biology to enable drug target discovery, drug repurposing, combinatorial therapeutics, and, ultimately, creating evidence to power life-saving decisions for patients and their families.

Webinar

The path to revolutionized cancer care: Accessing data to rapidly generate patient insights to impact care

March 10, 2022

Cancer Care is being revolutionized with real-world data, which tells a comprehensive story for cancer patients. Oncology and technology leaders are always searching for creative approaches to reduce the complexity of exchanging data across multiple platforms. However, when making a sizable investment in getting access to the data you need to inform clinical decision-making, it’s essential to have an engine that can provide out–of–the–box capabilities and the flexibility to manage customizations. In this fireside chat, health-tech experts from Syapse and Infor will discuss the benefits of working in tandem to streamline oncology data acquisition to improve outcomes for cancer patients.

News

01/05/2022

Illumina, Syapse Partner on Study of Comprehensive Genomic Profiling in Advanced Cancer

By Tiffany Druley

Syapse said on Tuesday that it has partnered with Illumina to assess uptake and…

Read

01/05/2022

Illumina and Syapse Partner on Biomarker Testing Research Across Oncology Practices

By Tiffany Druley

Syapse, a real-world evidence company that informs cancer care, announced a partnership with Illumina aimed at assessing the real-world uptake and actionability of comprehensive genomic profiling in the community oncology health system setting.

Read

01/04/2022

Illumina, Syapse Partner on Study of Comprehensive Genomic Profiling in Advanced Cancer

By Tiffany Druley

Syapse said on Tuesday that it has partnered with Illumina to assess uptake and actionability of comprehensive genomic profiling in the community oncology health system setting.

Read

Load more

Press Releases

07/27/2022

Syapse Announces $35 Million Growth Investment with Innovatus Capital Partners to Expand Delivery of Real-World Evidence Through Syapse’s Learning Health Network

By Chris Burkhardt

SAN FRANCISCO, NEW YORK, July 27, 2022 —Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced the closing of a $35 million growth funding transaction to expand Syapse’s focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer.

Read

06/14/2022

Syapse, Pierian Announce Genomics Collaboration to Power Precision Oncology

By Antoinette Cummins

SAN FRANCISCO, June 14, 2022 — Syapse®, a leading real-world evidence company announced with Pierian®, a global leader in advanced clinical genomics technology, a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida. The collaboration combines Syapse’s real-world evidence solutions designe…

Read

05/27/2022

Syapse Unveils Two New Studies on Use of Machine Learning on Real-World Data to Identify and Treat Cancer With Precision at ASCO 2022

By Antoinette Cummins

SAN FRANCISCO, May 27, 2022 – Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced two new studies focused on how the use of machine learning on real-world data can be used to power precision medicine solutions. Syapse will be presenting at th…

Read

Load more

Let's chat.

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.